explore -WSS

explore

author：fashion 2025-10-02 20:59:20 - browse：773

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Immunocompromised patients offer clues on chronic Covid

hotspot

WSS

CVS is on a mission to consolidate health care. Will it work?

CDC's new outbreak response network to include Northeastern

HPV vaccine, cervical cancer study delivers historic results

How AI helped researchers track recovery from depression

Emergency workers more likely to restrain Black patients: study

There's an unseen cost to disruptive road

entertainment

explore

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Medicare details structure of new drug price negotiation program

Maisha Meds is a PBM, but don't call it that

Psychedelics group wrestles with new pharma identity

Maisha Meds is a PBM, but don't call it that

Bright Health sells Medicare Advantage business to Molina

TikTok, Instagram influencers need more rules for drug ads

Peter Hotez and the public health issue of online harassment

CDC's new outbreak response network to include Northeastern

Affirmative action in medical school literally saved lives

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

explore

CommonSpirit Health keeps growing, even as it loses money

How Vertex's cystic fibrosis drug is changing patients' lives

CDC's new outbreak response network to include Northeastern

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Second xenotransplant done with gene

hotspot

hotspot

hotspot

knowledge